Basics of catecholamine use;Grundsatze der katecholamintherapie

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 35, Issue 3, 2000, Pages 131-136

  Gauss, A ^a   Anhaupi T ^a   Schutz W ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Acute heart failure catecholamines; Hypotension; Positive inotropic drugs; Septic schock; Shock

Indexed keywords

CATECHOLAMINE; INOTROPIC AGENT;

ACUTE HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART PRELOAD; HUMAN; HYPOTENSION; REVIEW; SEPTIC SHOCK; FORWARD HEART FAILURE; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION;

CARDIAC OUTPUT, LOW; CATECHOLAMINES; HUMANS; POSTOPERATIVE COMPLICATIONS; SHOCK, SEPTIC;

EID: 0034151930     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-10851     Document Type: Review

References (49)

1. Goldsmith SR, Dick C: Differentiating systolic from diastolic heart failure: pathophysiologic and therapeutic considerations. Am. J. Med. 1993; 95:645-655
2. Tardif J-C, Rouleau J-L: Diastolic dysfunction. Can.J. Cardiol. 1996; 12:389-398
3. Little WC, Applegate RJ: Congestive heart failure: Systolic and diastolic function. J. Cardiothorac. Vasc. Anesth. 1993; 7 (Suppl. 2): 2-5
4. Pagel PS: Left ventricular diastolic function in the normal and diseased heart. Perspectives for the anesthesiologist (first of two parts). Anesthesiology 1993; 79: 836-854
5. Labovitz AJ, Lewen MK, Kern M, Vandormael M, Deligonal U, Kennedy HL: Evaluation of left ventricular systolic and diastolic dysfunction during transient myocardial ischemia produced by angioplasty. J. Am. Coll. Cardiol. 1987; 10: 748-755
6. Grandi AM, Venco A, Sessa F, Gola A, Pantaleo P, Gobbi G, Baiardini R, Finardi G: Determinants of left ventricular function before and after regression of myocardial hypertrophy in hypertension. Am. J. Hypertens. 1993; 6: 708-712
7. Pagel PS, Grossmann W, Haering JM, Warltier DC: Left ventricular diastolic function in the normal and diseased heart: Perspectives for the anesthesiologist (second of two parts). Anesthesiology 1993; 79: 1104-1120
8. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 1992; 20: 864-874
9. Groeneveld ABJ, Schneider AJ, Thijs LG: Cardiac alterations in septic shock: pathophysiology, diagnosis, prognostic, and therapeutic implications. In: Update in Intensive Care and Emergency Medicine. Vincent J-L (Hrsg), Springer, Berlin 1991; 126-136
10. Parrillo JE: Mechanisms of Disease: Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 1993; 328: 1471-1477
11. Kumar A, Parrillo JE: Septic myocardial dysfunction: Role of cytokines and nitric oxide. In: Yearbook of Intensive Care and Emergency Medicine. Vincent J-L (Hrsg), Springer, Berlin 1997; 256-276
12. Walley KR: Ventricular dysfunction during sepsis. In: Yearbook of Intensive Care and Emergency Medicine. Vincent J-L (Hrsg), Springer, Berlin 1995; 505-517
13. Poelaert J, Declerck C, Vogelaers D, Colardyn F, Visser CA: Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997; 23: 553-560
14. Schremmer B, Dhainaut J-F: Heart failure in septic shock: Effects of inotropic support. Crit. Care Med. 1990; 18: 49-55
15. Meyer J, Hinder F, Traber DL: Nitric oxide synthase inhibition in septic shock. In: Yearbook of Intensive Care and Emergency Medicine. Vincent J-L (Hrsg), Springer, Berlin 1994; 64-73
16. Grant IS, Kelly KP, Mackenzie AF: Effects of catecholamine therapy on regional blood flow and tissue oxygenation in septic shock. In: Yearbook of Intensive Care and Emergency Medicine. Vincent J-L (Hrsg), Springer, Berlin 1994; 179-188
17. Giraud GD, MacCannell KL: Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation. J. Pharmacol. Exp. Ther. 1984; 230: 214-220
18. Cholley B, Payen D: Regulation of gut perfusion. In: Gut dysfunction in critical illness. Rombeau JL, Takala J (Hrsg), Springer, Berlin 1996; 53-64
19. TakalaJ: Effects of pharmacologic agents on splanchnic blood flow. In: Gut dysfunction in critical illness. Rombeau JL, Takala J (Hrsg), Springer, Berlin 1996; 264-279
20. Kulka PJ, Tryba M: Inotropic support of the critically ill patient. A review of the agents. Drugs 1993; 45: 654-667
21. Vincent J-L, van der Linden P: Septic shock: Particular type of acute circulatory failure. Crit. Care Med. 1990; 18: 70-74
22. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N. Engl. J. Med. 1994; 330: 1717-1722
23. Tuchschmidt J, Fried J, Astiz M, Rackow E: Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992; 102:216-220
24. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R: A trial of goal-oriented hemodynamic therapy in critically ill patients. N. Engl. J. Med. 1995; 333: 1025-1032
25. Bone HG, Sielenkämper A, Booke M: Sauerstoffangebot in der Sepsis. Anaesthesist 1999; 48: 63-79
26. Williams JF, Bristow MR, Fowler MB, Francis GS, Garson A, Gersh BJ, Hammer DF, Hlatky MA, Leier CV, Packer M, Pitt B, Ullyot DJ, Wexler LF, Winters WL: Guidelines for the evaluation and management of heart failure. Circulation 1995; 92: 2764-2784
27. Mager G, Höpp HW, Hilger HH: Digitails, Katecholamine und Vasodilatatoren bei Herzinsuffizienz. Internist 1992; 33: 631-638
28. Baumann G, Hader O: Pharmakotherapie der schweren Herzin-suffizienz mit Inodilatoren - Neue Ansätze. Z. Kardiol. 1996; 85 (Suppl. 4): 9-19
29. Antmann EM, Braunwald E: Acute myocardial infarction. In: Heart disease, a textbook of cardiovascular medicine. Braunwald E (Hrsg) 5. Aufl., W. B. Saunders, Philadelphia 1997; 1184-1288
30. Hopf H-B, Floßdorf T, Breulmann M: Rekombinanter Gewebeplasminogenaktivator (rt-PA) zur Notfallbehandlung der perioperativen lebensbedrohlichen Lungenembolie (Stadium IV). Ergebnisse bei sieben Patienten. Anaesthesist 1991; 40: 309-314
31. Girbes ARJ, Hoogenberg K: The use of dopamine and norepinephrine in the ICU. In: Yearbook of Intensive Care and Emergency Medicine. Vincent J-L (Hrsg). Springer, Berlin 1998; 178-187
32. Sibbald WJ, Vincent J-L: Round table conference on clinical trials for the treatment of sepsis. Crit. Care Med. 1995; 23: 394-399
33. Juste RN, Panikkar K, Soni N: The effects of low-dose dopamine infusion on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline. Intensive Care Med. 1998; 24: 564-568
34. Hoogenberg K, Smit AJ, Girbes ARJ: Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit. Care Med. 1998; 26: 260-265
35. Schaer GL, Fink MP, Parrillo JE: Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit. Care Med. 1985; 13: 492-496
36. Duke GJ, Briedis JH, Weaver RA: Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine? Crit. Care Med. 1994; 22: 1919-1925
37. Lherm T, Troche G, Rossignol M, Bordes M, Zazzo JF: Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med. 1996; 22: 213-219
38. Hannemann L, Reinhart K, Grenzer O, Meier-Hellmann A, Bredle DL: Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock. Crit. Care Med. 1995; 23: 1962-1970
39. Silverman HJ, Tuma P: Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red blood cell transfusions. Chest 1992; 102: 184-188
40. Gutierrez G, Clark C, Brown SD, Price K, Ortiz L, Nelson C: Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am. J. Respir. Crit. Care. Med. 1994; 150: 324-329
41. Shoemaker WC, Appel PL, Kram HB: Oxygen transport measurements to evaluate tissue perfusion and titrate therapy: dobutamine and dopamine effects. Crit. Care Med. 1991; 19: 672-688
42. Zadrobilek E: Klinik und Therapie des septischen Schocks. Anaesthesist 1993; 42: 657-671
43. Bearn AG, Billing B, Sherlock S: The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man. J. Physiol. 1951; 115: 430-441
44. 2 and metabolism transient? Intensive Care Med. 1995; 21:50-56
45. Nemes C, Niemer M: Sepsis. In: Datenbuch Intensivmedizin. Niemer M, Nemes C, Lundsgaard-Hansen P, Blauhut B (Hrsg) 3. Aufl. Gustav Fischer, Stuttgart 1992; pp. 1549-15617
46. Edwards JD: Clinical controversies concerning oxygen transport principles: More apparent than real? Yearbook of Intensive Care and Emergency Medicine, Edited by Vincent J-L Berlin, Springer 1993; pp. 385-405
47. Yu M, Burchell S, Hasaniya NWMA, Takanishi DM, Myers SA, Takiguchi SA: Relationship of mortality to increasing oxygen delivery in patients ≥ 50 years of age: a prospective, randomized trial. Crit. Care Med. 1998; 26: 1011-1019
48. Brinkmann A, Calcia E, Träger K, Radermacher P: Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance. Intensive Care Med. 1998; 24:542-556
49. Silva E, DeBacker D, Créteur J, Vincent J-L: Effects of vasoactive drugs on gastric intramucosal pH. Crit. Care Med. 1998; 26:1749-1758